Neonatal NET-Inhibitory Factor improves survival in the cecal ligation and puncture model of polymicrobial sepsis by inhibiting neutrophil extracellular traps.
Saved in:
| Title: | Neonatal NET-Inhibitory Factor improves survival in the cecal ligation and puncture model of polymicrobial sepsis by inhibiting neutrophil extracellular traps. |
|---|---|
| Authors: | de Araujo CV; Department of Pediatrics/Neonatology, University of Utah, Salt Lake City, UT, United States.; Molecular Medicine Program, University of Utah, Salt Lake City, UT, United States., Denorme F; Molecular Medicine Program, University of Utah, Salt Lake City, UT, United States., Stephens WZ; Department of Pathology, University of Utah, Salt Lake City, UT, United States., Li Q; High Throughput Genomics and Bioinformatic Analysis Shared Resource, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States., Cody MJ; Department of Pediatrics/Neonatology, University of Utah, Salt Lake City, UT, United States.; Molecular Medicine Program, University of Utah, Salt Lake City, UT, United States., Crandell JL; Molecular Medicine Program, University of Utah, Salt Lake City, UT, United States., Petrey AC; Molecular Medicine Program, University of Utah, Salt Lake City, UT, United States.; Department of Pathology, University of Utah, Salt Lake City, UT, United States., Queisser KA; Molecular Medicine Program, University of Utah, Salt Lake City, UT, United States.; Department of Pathology, University of Utah, Salt Lake City, UT, United States., Rustad JL; Molecular Medicine Program, University of Utah, Salt Lake City, UT, United States., Fulcher JM; Department of Biochemistry, University of Utah, Salt Lake City, UT, United States., Evangelista JL; Department of Biochemistry, University of Utah, Salt Lake City, UT, United States., Kay MS; Department of Biochemistry, University of Utah, Salt Lake City, UT, United States., Schiffman JD; Department of Pediatrics/Hematology-Oncology, University of Utah, Salt Lake City, UT, United States.; Peel Therapeutics, Inc., Salt Lake City, UT, United States., Campbell RA; Molecular Medicine Program, University of Utah, Salt Lake City, UT, United States.; Department of Internal Medicine, University of Utah, Salt Lake City, UT, United States., Yost CC; Department of Pediatrics/Neonatology, University of Utah, Salt Lake City, UT, United States.; Molecular Medicine Program, University of Utah, Salt Lake City, UT, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2023 Jan 17; Vol. 13, pp. 1046574. Date of Electronic Publication: 2023 Jan 17 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
